Answers are grounded in this paper and cite their sources.
In vitro study reveals antiosteoporotic activity of marine zoanthamine alkaloids in MG-63 cells, suggesting therapeutic leads for bone disease.
High Resolution Image Download MS PowerPoint Slide Extracts of the zoanthid from Zoanthus kuroshio (ZK) exhibited significant in vitro antiosteoporotic activity in MG-63 cells, prompting the use of Global Natural Products Social Molecular Networking (GNPS) to identify alkaloid-rich fractions. Subsequently, five new zoanthamine-type alkaloids, norzoabenzaldehyde ( 1 ), norzoazepanol ( 2 ), 3-acetoxynorzoanthaminone ( 3 ), 11-hydroxynorzoanthamide B ( 4 ), and 11-hydroxyzoanthamide B ( 5 ), were isolated. Structural elucidation was achieved by spectroscopic analyses, time-dependent density functional theory nuclear magnetic resonance (TDDFT-NMR) calculations, and electronic circular dichroism (ECD). The alkaloid 3-hydroxynorzoanthamine exhibited notable alkaline phosphatase activity and promoted mineralization, with an IC 50 value of 20 μM, underscoring its potential as a promising lead compound for the development of osteoporosis therapeutics.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: